Selection Criteria for De-Escalated Chemoradiotherapy for HPV-Related Oropharyngeal Cancer Based on Prognostic Biomarkers or Early Tumor Response to Therapy: A Narrative Review.
Review in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors.
Avraham EisbruchDepartment of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, USA.
M P SreeramDepartment of Head and Neck Oncology, Sri Shankara Cancer Foundation, Bangalore 560 004, India.
Karthik RaoDepartment of Head and Neck Oncology, Sri Shankara Cancer Foundation, Bangalore 560 004, India.ORCID 0000-0002-1420-7366
Abbas AgaimyInstitute of Pathology, Friedrich-Alexander-University Erlangen-Nuremberg, University Hospital, 91054 Erlangen, Germany.
Luiz P KowalskiDepartment of Head and Neck Surgery, University of São Paulo Medical School and AC Camargo Cancer Center, São Paulo 05403-000, Brazil.ORCID 0000-0002-0481-156X
Andrés Coca PelazDepartment of Otolaryngology, Hospital Universitario Central de Asturias, University of Oviedo, ISPA, IUOPA, CIBERONC, 33011 Oviedo, Spain.ORCID 0000-0003-1363-8559
Anna Luíza Damaceno AraújoHead and Neck Surgery Department and LIM 28, University of São Paulo Medical School and Hospital Israelita Albert Einstein, São Paulo 05508-020, Brazil.ORCID 0000-0002-3725-8051
Orlando Guntinas-LichiusENT Department, Jena University Hospital, 07747 Jena, Germany.ORCID 0000-0001-9671-0784
Juan P RodrigoDepartment of Otolaryngology, Hospital Universitario Central de Asturias, University of Oviedo, ISPA, IUOPA, CIBERONC, 33011 Oviedo, Spain.ORCID 0000-0003-3063-0890
Fernando LopezDepartment of Otolaryngology, Hospital Universitario Central de Asturias, University of Oviedo, ISPA, IUOPA, CIBERONC, 33011 Oviedo, Spain.
Sandra NuytsDepartment of Radiation Oncology, Leuven Cancer Institute, UZ Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-5540-4796
Nabil F SabaDepartment of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.ORCID 0000-0003-4972-1477
Arlene ForastiereThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.ORCID 0000-0003-2238-3682
Carol R BradfordCollege of Medicine, The Ohio State University, Columbus, OH 43201, USA.
Alfio FerlitoCoordinator of the International Head and Neck Scientific Group, 35100 Padua, Italy.ORCID 0000-0002-8247-8002
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Selection Criteria for De-Escalated Chemoradiotherapy for HPV-Related Oropharyngeal Cancer Based on Prognostic Biomarkers or Early Tumor Response to Therapy: A Narrative Review. · full record | OpenQuestion